Global Gout Disease Treatment Market Research Report 2023

Publisher Name :
Date: 14-Dec-2023
No. of pages: 87
Inquire Before Buying

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gout Disease Treatment market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Takeda Pharmaceutical

- Novartis

- Savient Pharmaceuticals

- AstraZeneca

- GlaxoSmithKline

- Merck& Co

- Teijin Pharma

- Regeneron Pharmaceuticals

- Polaris

- BioCryst Pharmaceuticals

- Nippon Chemiphar

- JW Pharmaceutical

Segment by Type

- Acute Gout

- Chronic Gout

Segment by Application

- Hospitals

- Clinics

- Homecare Settings

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

The Gout Disease Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies' Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies' Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Global Gout Disease Treatment Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gout Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Acute Gout
1.2.3 Chronic Gout
1.3 Market by Application
1.3.1 Global Gout Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare Settings
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gout Disease Treatment Market Perspective (2018-2029)
2.2 Gout Disease Treatment Growth Trends by Region
2.2.1 Global Gout Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gout Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Gout Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Gout Disease Treatment Market Dynamics
2.3.1 Gout Disease Treatment Industry Trends
2.3.2 Gout Disease Treatment Market Drivers
2.3.3 Gout Disease Treatment Market Challenges
2.3.4 Gout Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gout Disease Treatment Players by Revenue
3.1.1 Global Top Gout Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Gout Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Gout Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gout Disease Treatment Revenue
3.4 Global Gout Disease Treatment Market Concentration Ratio
3.4.1 Global Gout Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gout Disease Treatment Revenue in 2022
3.5 Gout Disease Treatment Key Players Head office and Area Served
3.6 Key Players Gout Disease Treatment Product Solution and Service
3.7 Date of Enter into Gout Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gout Disease Treatment Breakdown Data by Type
4.1 Global Gout Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Gout Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Gout Disease Treatment Breakdown Data by Application
5.1 Global Gout Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Gout Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gout Disease Treatment Market Size (2018-2029)
6.2 North America Gout Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gout Disease Treatment Market Size by Country (2018-2023)
6.4 North America Gout Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gout Disease Treatment Market Size (2018-2029)
7.2 Europe Gout Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gout Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Gout Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gout Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Gout Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gout Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Gout Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gout Disease Treatment Market Size (2018-2029)
9.2 Latin America Gout Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gout Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Gout Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gout Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Gout Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gout Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Gout Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Gout Disease Treatment Introduction
11.1.4 Takeda Pharmaceutical Revenue in Gout Disease Treatment Business (2018-2023)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gout Disease Treatment Introduction
11.2.4 Novartis Revenue in Gout Disease Treatment Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Savient Pharmaceuticals
11.3.1 Savient Pharmaceuticals Company Detail
11.3.2 Savient Pharmaceuticals Business Overview
11.3.3 Savient Pharmaceuticals Gout Disease Treatment Introduction
11.3.4 Savient Pharmaceuticals Revenue in Gout Disease Treatment Business (2018-2023)
11.3.5 Savient Pharmaceuticals Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Gout Disease Treatment Introduction
11.4.4 AstraZeneca Revenue in Gout Disease Treatment Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gout Disease Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Gout Disease Treatment Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck& Co
11.6.1 Merck& Co Company Detail
11.6.2 Merck& Co Business Overview
11.6.3 Merck& Co Gout Disease Treatment Introduction
11.6.4 Merck& Co Revenue in Gout Disease Treatment Business (2018-2023)
11.6.5 Merck& Co Recent Development
11.7 Teijin Pharma
11.7.1 Teijin Pharma Company Detail
11.7.2 Teijin Pharma Business Overview
11.7.3 Teijin Pharma Gout Disease Treatment Introduction
11.7.4 Teijin Pharma Revenue in Gout Disease Treatment Business (2018-2023)
11.7.5 Teijin Pharma Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Detail
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Gout Disease Treatment Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Gout Disease Treatment Business (2018-2023)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Polaris
11.9.1 Polaris Company Detail
11.9.2 Polaris Business Overview
11.9.3 Polaris Gout Disease Treatment Introduction
11.9.4 Polaris Revenue in Gout Disease Treatment Business (2018-2023)
11.9.5 Polaris Recent Development
11.10 BioCryst Pharmaceuticals
11.10.1 BioCryst Pharmaceuticals Company Detail
11.10.2 BioCryst Pharmaceuticals Business Overview
11.10.3 BioCryst Pharmaceuticals Gout Disease Treatment Introduction
11.10.4 BioCryst Pharmaceuticals Revenue in Gout Disease Treatment Business (2018-2023)
11.10.5 BioCryst Pharmaceuticals Recent Development
11.11 Nippon Chemiphar
11.11.1 Nippon Chemiphar Company Detail
11.11.2 Nippon Chemiphar Business Overview
11.11.3 Nippon Chemiphar Gout Disease Treatment Introduction
11.11.4 Nippon Chemiphar Revenue in Gout Disease Treatment Business (2018-2023)
11.11.5 Nippon Chemiphar Recent Development
11.12 JW Pharmaceutical
11.12.1 JW Pharmaceutical Company Detail
11.12.2 JW Pharmaceutical Business Overview
11.12.3 JW Pharmaceutical Gout Disease Treatment Introduction
11.12.4 JW Pharmaceutical Revenue in Gout Disease Treatment Business (2018-2023)
11.12.5 JW Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gout Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Acute Gout
Table 3. Key Players of Chronic Gout
Table 4. Global Gout Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gout Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gout Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gout Disease Treatment Market Share by Region (2018-2023)
Table 8. Global Gout Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gout Disease Treatment Market Share by Region (2024-2029)
Table 10. Gout Disease Treatment Market Trends
Table 11. Gout Disease Treatment Market Drivers
Table 12. Gout Disease Treatment Market Challenges
Table 13. Gout Disease Treatment Market Restraints
Table 14. Global Gout Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gout Disease Treatment Market Share by Players (2018-2023)
Table 16. Global Top Gout Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Disease Treatment as of 2022)
Table 17. Ranking of Global Top Gout Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gout Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gout Disease Treatment Product Solution and Service
Table 21. Date of Enter into Gout Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gout Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gout Disease Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Gout Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gout Disease Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Gout Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gout Disease Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Gout Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gout Disease Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Gout Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gout Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gout Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gout Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gout Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gout Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gout Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gout Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gout Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gout Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gout Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gout Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gout Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gout Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gout Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Takeda Pharmaceutical Company Detail
Table 47. Takeda Pharmaceutical Business Overview
Table 48. Takeda Pharmaceutical Gout Disease Treatment Product
Table 49. Takeda Pharmaceutical Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 50. Takeda Pharmaceutical Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gout Disease Treatment Product
Table 54. Novartis Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Savient Pharmaceuticals Company Detail
Table 57. Savient Pharmaceuticals Business Overview
Table 58. Savient Pharmaceuticals Gout Disease Treatment Product
Table 59. Savient Pharmaceuticals Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 60. Savient Pharmaceuticals Recent Development
Table 61. AstraZeneca Company Detail
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Gout Disease Treatment Product
Table 64. AstraZeneca Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gout Disease Treatment Product
Table 69. GlaxoSmithKline Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Merck& Co Company Detail
Table 72. Merck& Co Business Overview
Table 73. Merck& Co Gout Disease Treatment Product
Table 74. Merck& Co Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 75. Merck& Co Recent Development
Table 76. Teijin Pharma Company Detail
Table 77. Teijin Pharma Business Overview
Table 78. Teijin Pharma Gout Disease Treatment Product
Table 79. Teijin Pharma Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 80. Teijin Pharma Recent Development
Table 81. Regeneron Pharmaceuticals Company Detail
Table 82. Regeneron Pharmaceuticals Business Overview
Table 83. Regeneron Pharmaceuticals Gout Disease Treatment Product
Table 84. Regeneron Pharmaceuticals Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Recent Development
Table 86. Polaris Company Detail
Table 87. Polaris Business Overview
Table 88. Polaris Gout Disease Treatment Product
Table 89. Polaris Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 90. Polaris Recent Development
Table 91. BioCryst Pharmaceuticals Company Detail
Table 92. BioCryst Pharmaceuticals Business Overview
Table 93. BioCryst Pharmaceuticals Gout Disease Treatment Product
Table 94. BioCryst Pharmaceuticals Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 95. BioCryst Pharmaceuticals Recent Development
Table 96. Nippon Chemiphar Company Detail
Table 97. Nippon Chemiphar Business Overview
Table 98. Nippon Chemiphar Gout Disease Treatment Product
Table 99. Nippon Chemiphar Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 100. Nippon Chemiphar Recent Development
Table 101. JW Pharmaceutical Company Detail
Table 102. JW Pharmaceutical Business Overview
Table 103. JW Pharmaceutical Gout Disease Treatment Product
Table 104. JW Pharmaceutical Revenue in Gout Disease Treatment Business (2018-2023) & (US$ Million)
Table 105. JW Pharmaceutical Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gout Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gout Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Acute Gout Features
Figure 4. Chronic Gout Features
Figure 5. Global Gout Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gout Disease Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Homecare Settings Case Studies
Figure 10. Others Case Studies
Figure 11. Gout Disease Treatment Report Years Considered
Figure 12. Global Gout Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Gout Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gout Disease Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Gout Disease Treatment Market Share by Players in 2022
Figure 16. Global Top Gout Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Disease Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gout Disease Treatment Revenue in 2022
Figure 18. North America Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Gout Disease Treatment Market Share by Country (2018-2029)
Figure 20. United States Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gout Disease Treatment Market Share by Country (2018-2029)
Figure 24. Germany Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Gout Disease Treatment Market Share by Region (2018-2029)
Figure 32. China Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Gout Disease Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Gout Disease Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Gout Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Takeda Pharmaceutical Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 48. Savient Pharmaceuticals Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 49. AstraZeneca Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 51. Merck& Co Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 52. Teijin Pharma Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 53. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 54. Polaris Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 55. BioCryst Pharmaceuticals Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 56. Nippon Chemiphar Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 57. JW Pharmaceutical Revenue Growth Rate in Gout Disease Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs